HCA Healthcare, Inc.
- Stock
- Ticker HCA
- ISIN US40412C1018
- NYSE
Performance, volatility and drawdowns of HCA Healthcare, Inc. since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $70,619. Global equities (VT): $29,042.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −54.7% in 03/2020, measured from the peak in 02/2020. It took 9 months to get back to the old peak.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 18,285 | 18,321 | 18,605 | 19,161 | 19,513 | 19,109 | 20,230 | 19,849 |
| Net income | 1,438 | 1,610 | 1,653 | 1,643 | 1,878 | 1,620 | 1,699 | 1,579 |
| Earnings per share | 5.63 | 6.45 | 6.83 | 6.96 | 8.10 | 7.15 | 7.62 | 7.27 |
| Balance sheet | ||||||||
| Total assets | 59,513 | 59,798 | 59,536 | 59,747 | 60,720 | 61,450 | 63,250 | 63,452 |
| Liabilities | 58,958 | 60,236 | 60,774 | 61,906 | 63,491 | 64,428 | 66,459 | 68,051 |
| Equity | -2,499 | -3,519 | -4,394 | -5,335 | -6,027 | -6,303 | -6,642 | -8,077 |
| Cash | 1,933 | 1,060 | 939 | 997 | 1,040 | 940 | 1,013 | 908 |
| Long-term debt | 38,333 | 41,057 | 39,379 | 38,401 | 41,603 | 39,491 | 43,454 | 42,400 |
| Cash flow | ||||||||
| Operating cash flow | 2,559 | 1,651 | 4,210 | 4,416 | 2,359 | 2,014 | 2,335 | 4,461 |
| Capital expenditure | -1,285 | -991 | -1,176 | -1,288 | -1,489 | -1,119 | -1,231 | -1,357 |
| Free cash flow | 1,274 | 660 | 3,034 | 3,128 | 870 | 895 | 1,104 | 3,104 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2021 at +57.6%, weakest 2022 at −5.6%. 8 of 9 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 29 Oct 2026 | $7.27 |
| 28 Jul 2026 | $7.62 |
| 29 Apr 2026 | $7.15 |
| 10 Feb 2026 | $8.10 |
| 30 Oct 2025 | $6.96 |
| 4 Aug 2025 | $6.83 |
| 1 May 2025 | $6.45 |
| 14 Feb 2025 | $5.63 |
| 31 Oct 2024 | $4.88 |
| 29 Jul 2024 | $5.53 |
| 2 May 2024 | $5.93 |
| 16 Feb 2024 | $5.90 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €90bn
- Market cap in trading currency
- $99.3bn
- Enterprise value
- $143bn
- P/E
- 15.8
- P/S
- 1.26
- P/B
- –
- EV/Sales
- 1.82
- EV/EBITDA
- 9.0
- Earnings yield
- 6.3%
- FCF yield
- 6.0%
Results (last four quarters)
- Revenue
- $78.7bn
- Gross profit
- –
- EBITDA
- $15.9bn
- Net income
- $6.78bn
- Earnings per share
- $30.14
- Revenue per share
- $376.75
- Revenue growth
- +3.6%
- Earnings growth
- −3.9%
Profitability
- Gross margin
- –
- Operating margin
- 15.5%
- Net margin
- 8.6%
- Return on equity
- –
- Return on assets
- 10.7%
Balance sheet and cash flow
- Cash
- $908m
- Cash per share
- $4.35
- Financial debt
- $44.8bn
- Debt/equity %
- –
- Current ratio
- 0.82
- Book value per share
- −$38.67
- Operating cash flow
- $11.2bn
- Free cash flow
- $5.97bn
Dividend
- Dividend yield
- 0.64%
- Dividend (12 months)
- $3.06
- Yield (12 months)
- 0.64%
- Payout ratio
- 10%
- Ex-dividend date
- 16 Sep 2026
Shares and trading
- Shares outstanding
- 209m
- Volume
- 1.58m
- Avg. volume 3 months
- 1.37m
- Relative volume
- 1.2
Price and technicals
- Price
- $475.57
- 1 day
- +3.3%
- 52-week high
- $545.13
- 52-week low
- $361.32
- Distance to 52-week high
- −12.8%
- Distance to 52-week low
- +31.6%
- Distance to 50-day line
- +3.4%
- Distance to 200-day line
- +6.9%
- RSI (14)
- 49
- Volatility 1M
- 50.4%
Performance
- 1 week
- −4.7%
- 1 month
- +1.8%
- 3 months
- +10.8%
- 6 months
- +20.7%
- YTD
- +1.9%
- 1 year
- −1.1%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has HCA performed since 11/2016?
$10,000 grew to $70,619 by 20 Nov 2026, which is +21.6% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is HCA?
Volatility was 33.5% per year, measured on monthly returns. The largest decline from a peak was −54.7%, with the low in 03/2020.
How does HCA compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, HCA returned +21.6% at 33.5%. The correlation of monthly returns was 0.63; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.